BiotechTube

Tirbanibulin

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 34/100
34
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Keratosis, Actinic

Conditions

Keratosis, Actinic

Trial Timeline

Dec 21, 2023 → Nov 25, 2025

NCT ID
NCT06135415

About Tirbanibulin

Tirbanibulin is a phase 3 stage product being developed by Almirall for Keratosis, Actinic. The current trial status is completed. This product is registered under clinical trial identifier NCT06135415. Target conditions include Keratosis, Actinic.

What happened to similar drugs?

5 of 20 similar drugs in Keratosis, Actinic were approved

Approved (5) Terminated (0) Active (15)
🔄Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%Sun PharmaceuticalPhase 3
🔄Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%Sun PharmaceuticalPhase 3
🔄KX01 ointment 1% + PlaceboPharmaEssentiaPhase 3
✅Imiquimod + DiclofenacViatrisApproved
🔄Aldara (Imiquimod)ViatrisPhase 3
✅Imiquimod + DiclofenacViatrisApproved
🔄Placebo Gel + LAS41005 + LAS106521AlmirallPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT06135415Phase 3Completed
NCT06026358ApprovedWithdrawn
NCT05260073Pre-clinicalCompleted

Competing Products

20 competing products in Keratosis, Actinic

See all competitors
ProductCompanyStageHype Score
Low dose DFD07 once daily + High dose DFD07 once daily + High dose DFD07 twice daily + Placebo twice dailyDr. Reddy's LaboratoriesPhase 2/3
35
Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%Sun PharmaceuticalPhase 3
44
Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%Sun PharmaceuticalPhase 3
44
Diclofenac Sodium Gel 3% + Solaraze® (diclofenac sodium) Gel 3% + Vehicle Topical GelSun PharmaceuticalPhase 1
29
Imiquimod Topical Cream 3.75% + Zyclara® (imiquimod) Topical Cream 3.75% + Vehicle Topical CreamSun PharmaceuticalPhase 1
29
Imiquimod 5% manufactured by Taro + Aldara - Imiquimod 5% + Imiquimod Vehicle manufactured by TaroSun PharmaceuticalPhase 1
29
Investigational Treatment + Active comparatorNovartisPhase 2
35
KX01 ointment 1% + PlaceboPharmaEssentiaPhase 3
40
Imiquimod + DiclofenacViatrisApproved
40
Imiquimod 5 % CreamViatrisPhase 2
32
Aldara (Imiquimod)ViatrisPhase 3
37
Imiquimod + DiclofenacViatrisApproved
40
Placebo Gel + LAS41005 + LAS106521AlmirallPhase 3
34
5-fluorouracil/salicylic acid + VehicleAlmirallPhase 3
34
50 mg of KX2-391 Ointment 1% + 50 mg of KX2-391 Ointment 1%AlmirallPhase 2
29
Tirbanibulin (Klisyri®) 10 mg/g ointment + Diclofenac Sodium 3% GelAlmirallApproved
41
KX2-391 Ointment 1% + PlaceboAlmirallPhase 3
34
Tirbanibulin 2.5 mg ointmentAlmirallApproved
37
LAS41005AlmirallPhase 2
29
Cryotherapy + TirbanibulinAlmirallPhase 3
41